SCHEMBL5986963

SCHEMBL5986963

CCCCCCCC/C=C\CCCCCCCCC1=NC(C)(CO)CO1

nearest known ligand 0.52

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 2/20 0.38
CDC25A P30304 1/20 0.36
CDC25B P30305 1/20 0.36
CDC25C P30307 1/20 0.36
PRKCA P17252 9/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL677126 1.00 EPHX2 (0.38) EPHX2CDC25ACDC25BCDC25CPRKCA
SCHEMBL677125 1.00 EPHX2 (0.38) EPHX2CDC25ACDC25BCDC25CPRKCA
SCHEMBL5986968 1.00 EPHX2 (0.38) EPHX2CDC25ACDC25BCDC25CPRKCA
SCHEMBL9787920 0.91 PRKCA (0.34) PRKCA
SCHEMBL10618565 0.91 PRKCA (0.34) PRKCA
SCHEMBL10619653 0.91 PRKCA (0.34) PRKCA
SCHEMBL10491918 0.91 PRKCA (0.34) PRKCA
SCHEMBL9787876 0.91 PRKCA (0.34) PRKCA
SCHEMBL676589 0.91 PRKCA (0.34) PRKCA
SCHEMBL11210120 0.89 PRKCA (0.36) PRKCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020155962-A1 Nonaqueous hair styling composition and method of use ANDREW JERGENS COMPANY, THE 2002-10-24 US claimed
US-12527733-B2 Fragrance compositions ELC MANAGEMENT LLC (US) 2026-01-20 US disclosed
EP-4384137-A1 FRAGRANCE COMPOSITIONS ELC Management LLC (US) 2024-06-19 EP disclosed
EP-3141239-B1 FRAGRANCE COMPOSITIONS AND USES THEREOF PROCTER & GAMBLE (US) 2023-05-10 EP disclosed
WO-2023018673-A1 FRAGRANCE COMPOSITIONS ELC MANAGEMENT LLC (US) 2023-02-16 WO disclosed
US-20230048533-A1 FRAGRANCE COMPOSITIONS ELC MANAGEMENT LLC 2023-02-16 US disclosed
US-20210393506-A1 FRAGRANCE BLENDS AND METHODS FOR PREPARATION THEREOF JPMORGAN CHASE BANK, N.A. 2021-12-23 US disclosed
WO-2020097181-A9 FRAGRANCE BLENDS AND METHODS FOR PREPARATION THEREOF COTY INC. (US) 2021-01-14 WO disclosed
EP-3141239-A1 FRAGRANCE COMPOSITIONS AND USES THEREOF The Procter and Gamble Company (US) 2017-03-15 EP disclosed
US-20060110379-A1 Linkage of agents using microparticles PERICOR SCIENCE, INC. (US) 2006-05-25 US disclosed
US-6919076-B1 Conjugates of agents and transglutaminase substrate linking molecules PERICOR SCIENCE, INC. (US) 2005-07-19 US disclosed
US-6861397-B2 Compositions having enhanced deposition of a topically active compound on a surface THE DIAL CORPORATION (US) 2005-03-01 US disclosed
US-6706674-B2 CONTAINING A VINYL INTERPOLYMER SUCH AS A VINYL ACETATE-VINYL PYRROLIDONE COPOLYMER OR TERPOLYMER WITH VINYL PROPIONATE OR SODIUM ACRYLATE-VINYL ALCOHOL COPOLYMER THE ANDREW JERGENS COMPANY 2004-03-16 US disclosed
EP-1303260-A2 LINKAGE OF AGENTS USING MICROPARTICLES Pericor Science, Inc. (US) 2003-04-23 EP disclosed
US-20020155962-A1 Nonaqueous hair styling composition and method of use ANDREW JERGENS COMPANY, THE 2002-10-24 US disclosed
EP-1203141-A1 LINKAGE OF AGENTS TO TISSUE Pericor Science, Inc. (US) 2002-05-08 EP disclosed
EP-1202706-A1 LYSINE OXIDASE LINKAGE OF AGENTS TO TISSUE Pericor Science, Inc. (US) 2002-05-08 EP disclosed
WO-2002007707-A2 LINKAGE OF AGENTS USING MICROPARTICLES PERICOR SCIENCE, INC. (US) 2002-01-31 WO disclosed
WO-2001007009-A1 LYSINE OXIDASE LINKAGE OF AGENTS TO TISSUE PERICOR SCIENCE, INC. (US) 2001-02-01 WO disclosed
WO-2001006829-A2 LINKAGE OF AGENTS TO TISSUE PERICOR SCIENCE, INC. (US) 2001-02-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12527733-B2 Fragrance compositions CUTA, IL36G, TAS2R40 EPHX2 1426/4885CDC25A 4081/4885CDC25B 4212/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.